OTC Markets OTCQB - Delayed Quote USD
NervGen Pharma Corp. (NGENF)
2.1300
-0.0200
(-0.93%)
At close: April 23 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
Adams (William James) Senior Officer of Issuer | Acquisition or disposition under a prospectus | Mar 28, 2024 | -- |
Ives (Glenn Antony) Director of Issuer | Acquisition or disposition under a prospectus | Mar 28, 2024 | -- |
Kaye (Randall E) Director of Issuer | Acquisition or disposition under a prospectus | Mar 28, 2024 | 10,000 |
Kelly (Michael) Director of Issuer | Acquisition or disposition under a prospectus | Mar 28, 2024 | 143,957 |
Mckerracher (Krista L) Director of Issuer | Acquisition or disposition under a prospectus | Mar 28, 2024 | 5,758 |
PFP Biosciences Holdings LLC 10% Security Holder of Issuer | Acquisition or disposition under a prospectus | Mar 28, 2024 | -- |
Punnett, Harold 10% Security Holder of Issuer | Acquisition or disposition under a prospectus | Mar 28, 2024 | 1,125,532 |
Radvak (William Joseph) Director of Issuer | Acquisition or disposition carried out privately | Mar 28, 2024 | 1,407,500 |
Ruffolo (John) Director of Issuer | Acquisition or disposition under a prospectus | Mar 28, 2024 | -- |
Related Tickers
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
MSCLF Satellos Bioscience Inc.
0.5020
0.00%
EPRX Eupraxia Pharmaceuticals Inc.
3.8400
-0.26%
MSCL.TO Satellos Bioscience Inc.
0.6900
+11.29%
BETRF BetterLife Pharma Inc.
0.0680
0.00%
APTOF Aptose Biosciences Inc.
2.3100
-6.48%
ACHV Achieve Life Sciences, Inc.
2.4300
-2.02%
ARTH Arch Therapeutics, Inc.
0.1608
0.00%
FENC Fennec Pharmaceuticals Inc.
5.65
+3.86%